Century Therapeutics Inc (IPSC)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current IPSC market cap is 51.87M. The company's latest EPS is USD -1.4690 and P/E is -0.43.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 855k | 770k | 791k | 4.17M | 109.16M |
| Operating Income | -31.31M | -34.76M | -34.79M | -37.28M | 74.18M |
| Net Income | -28.06M | -31.21M | -31.22M | -36.07M | 76.56M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 5.2M | 2.24M | 6.59M |
| Operating Income | -53.9M | -94.88M | -133.83M | -130.18M | -138.14M |
| Net Income | -53.58M | -95.82M | -130.93M | -136.67M | -126.57M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 348.51M | 416.45M | 388.62M | 353.22M | 315.61M |
| Total Liabilities | 170.62M | 194.34M | 192.93M | 191.85M | 75.17M |
| Total Equity | 177.88M | 222.1M | 195.69M | 161.36M | 240.44M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.78M | 437.38M | 486.54M | 360.69M | 353.22M |
| Total Liabilities | 33.43M | 41.14M | 183.81M | 175.94M | 191.85M |
| Total Equity | -106.41M | 396.24M | 302.74M | 184.75M | 161.36M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.25M | -57.58M | -85.89M | -110.14M | -34.62M |
| Investing | 11.54M | -22.32M | 16.88M | 47.48M | 27.93M |
| Financing | 18.2M | 74.89M | 75.17M | 74.56M | 120k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -41.27M | -89M | 14.05M | -88.35M | -110.14M |
| Investing | -22.76M | -298.34M | -13.13M | 61.13M | 47.48M |
| Financing | 47.69M | 417.77M | 27.16M | -9.73M | 74.56M |
| Market Cap | 51.87M |
| Price to Earnings Ratio | -0.43 |
| Price to Sales Ratio | 8.24 |
| Price to Cash Ratio | 0.93 |
| Price to Book Ratio | 0.34 |
| Dividend Yield | - |
| Shares Outstanding | 86.16M |
| Average Volume (1 week) | 437.25k |
| Average Volume (1 Month) | 947.2k |
| 52 Week Change | -73.71% |
| 52 Week High | 3.29 |
| 52 Week Low | 0.3418 |
| Spread (Intraday) | 0.02 (3.06%) |
| Company Name | Century Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.centurytx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
